Wed, January 27, 2021

Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $28 on, Jan 27th, 2021

Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Increased Target from $24 to $28 on, Jan 27th, 2021.

Joseph has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $35 on, Monday, January 25th, 2021